Skip to main content
Top
Published in: Hepatology International 2/2024

23-12-2023 | Esophageal Varices | Letter to the Editor

Editorial: The safety profile of endoscopic variceal ligation in patients with esophageal varices. Authors’ reply

Authors: N. Pfisterer, M. Schwarz, C. Madl, M. Mandorfer, T. Reiberger

Published in: Hepatology International | Issue 2/2024

Login to get access

Excerpt

We appreciate the valuable thoughts on our study demonstrating that endoscopic band ligation (EBL) is safe, even in patients with low platelet count and high INR. [1]. …
Literature
2.
go back to reference Veitch AM, Radaelli F, Alikhan R, Dumonceau JM, Eaton D, Jerrome J, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update. Gut. 2021;70:1611–1628CrossRefPubMed Veitch AM, Radaelli F, Alikhan R, Dumonceau JM, Eaton D, Jerrome J, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guideline update. Gut. 2021;70:1611–1628CrossRefPubMed
3.
go back to reference de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Abraldes JG, et al. Baveno VII—renewing consensus in portal hypertension. J Hepatol. 2022;76:959–974CrossRefPubMed de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C, Abraldes JG, et al. Baveno VII—renewing consensus in portal hypertension. J Hepatol. 2022;76:959–974CrossRefPubMed
4.
go back to reference Krige J, Jonas E, Kotze U, Kloppers C, Gandhi K, Allam H, et al. Defining the advantages and exposing the limitations of endoscopic variceal ligation in controlling acute bleeding and achieving complete variceal eradication. World J Gastrointest Endosc. 2020;12:365–377CrossRefPubMedPubMedCentral Krige J, Jonas E, Kotze U, Kloppers C, Gandhi K, Allam H, et al. Defining the advantages and exposing the limitations of endoscopic variceal ligation in controlling acute bleeding and achieving complete variceal eradication. World J Gastrointest Endosc. 2020;12:365–377CrossRefPubMedPubMedCentral
5.
go back to reference Nass KJ, Zwager LW, van der Vlugt M, Dekker E, Bossuyt PMM, Ravindran S, et al. Novel classification for adverse events in GI endoscopy: the AGREE classification. Gastrointest Endosc. 2022;95:1078-1085.e8CrossRefPubMed Nass KJ, Zwager LW, van der Vlugt M, Dekker E, Bossuyt PMM, Ravindran S, et al. Novel classification for adverse events in GI endoscopy: the AGREE classification. Gastrointest Endosc. 2022;95:1078-1085.e8CrossRefPubMed
Metadata
Title
Editorial: The safety profile of endoscopic variceal ligation in patients with esophageal varices. Authors’ reply
Authors
N. Pfisterer
M. Schwarz
C. Madl
M. Mandorfer
T. Reiberger
Publication date
23-12-2023
Publisher
Springer India
Published in
Hepatology International / Issue 2/2024
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-023-10617-7

Other articles of this Issue 2/2024

Hepatology International 2/2024 Go to the issue

Abstracts

Abstracts

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.